Headquartered in Paris, Majorelle is a French specialty pharma company focused on prescription and OTC products in women’s health and urology that offer health solutions for men and women in France.

Since its founding in 2012, Majorelle has developed the most relevant and dynamic women’s health product range in the French market, meeting unmet medical needs, making new treatments available to patients, and offering significant public health outcomes. 

Upon completion of the transaction, the Founders will retain a minority stake in the company and will work closely together with EW Healthcare Partners.

The Reed Smith team that advised on the deal was led by partner Guilain Hippolyte, with support from partners Séverine Martel, Natasha Tardif, Daniel Kadar, Sam Webster and associates Charlotte Grolimund, Marine Deyrolle, Fanny Molla, Khushbu Kumar, Stéphanie Abdesselam, Victoria Bryden, and Yexi Tran. 

The Reed Smith team provided advice ranging from corporate, labour & employment, regulatory to data protection law. PwC provided financial, accounting and tax advice. Kirkland & Ellis provided debt finance advice. Bryan Garnier & Co acted as financial adviser to the Founders, and August Debouzy and Odinot & Associés served as legal advisers to the Founders and Majorelle.